Anzeige
Mehr »
Login
Freitag, 07.05.2021 Börsentäglich über 12.000 News von 660 internationalen Medien
Besonderer Geheimtipp! Eine geheime Rallye(-vorbereitung)…?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JDME ISIN: CA8834261080 Ticker-Symbol: JNX 
Stuttgart
07.05.21
18:02 Uhr
0,270 Euro
-0,005
-1,82 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
THERMA BRIGHT INC Chart 1 Jahr
5-Tage-Chart
THERMA BRIGHT INC 5-Tage-Chart

Aktuelle News zur THERMA BRIGHT Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoTherma Bright to distribute a 15-minute rapid COVID-19 antibody test1
THERMA BRIGHT Aktie jetzt für 0€ handeln
DoTherma Bright Inc: Therma Bright to distribute COVID-19 antibody test-
DoTherma Bright Inc.: Therma Bright Enters into Agreement to Distribute a 15 Minute Rapid COVID-19 Antibody Test70Toronto, Ontario--(Newsfile Corp. - May 6, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the AcuVid COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic...
► Artikel lesen
28.04.Therma Bright Inc: Therma adds Afero's tracking to AcuVid test1
28.04.Therma Bright Inc.: Therma Bright Partners With Afero To Make AcuVid COVID-19 Rapid Antigen Saliva Test Smart-Enabled235Silicon Valley tech firm brings encrypted solution for tracking Canadian developer's 15-minute Covid19 rapid antigen test for point of care, and then at-home testing Toronto, Ontario--(Newsfile Corp....
► Artikel lesen
22.04.Therma Bright Inc: Therma Bright's AcuVid detects COVID-19 variants2
22.04.Therma Bright Inc.: Therma Bright's AcuVid COVID-19 Rapid Antigen Saliva Test Detects the Important SARS-CoV-2 Variants of Concern; the Brazilian P.1 and P.2 and the UK B.1.1.7 Variants339Toronto, Ontario--(Newsfile Corp. - April 22, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the AcuVid COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic...
► Artikel lesen
19.04.Therma Bright Inc: Therma Bright receives CE certification for AcuVid5
19.04.Therma Bright gets EU-CE approval for AcuVid COVID-19 rapid antigen saliva test-
19.04.Therma Bright Inc.: Therma Bright Announces EU-CE Approval for AcuVid COVID-19 Rapid Antigen Saliva Test and Conditional Sale for 100,000 CE-only AcuVid Test Kits178New global distribution partner McWilliams Collective secures test kit order from European client Toronto, Ontario--(Newsfile Corp. - April 19, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or...
► Artikel lesen
13.04.Therma Bright Inc: Therma Bright completes phase of AcuVid study in Brazil8
13.04.Therma Bright Inc.: Therma Bright Provides Update on Brazilian Performance Study of its AcuVid COVID-19 Rapid Saliva-Based Antigen Test308Toronto, Ontario--(Newsfile Corp. - April 13, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the AcuVid Covid-19 Rapid Antigen Saliva Test and other progressive diagnostic...
► Artikel lesen
30.03.Therma Bright Inc: Therma Bright 866,664 shares for debt11
25.03.Therma Bright Inc: Therma Bright receives IRB approval for AcuVid study6
25.03.Therma Bright Inc.: Therma Bright Receives IRB Approval and Submits Application to Health Canada to Begin Clinical Study for its AcuVid COVID-19 Rapid Saliva-Based Antigen Test314Toronto, Ontario--(Newsfile Corp. - March 25, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the AcuVid Covid-19 Rapid Antigen Saliva Test and other progressive diagnostic...
► Artikel lesen
24.03.Therma Bright climbs 13% on partnership with consultancy founded by former secretary of Homeland Security2
24.03.Therma Bright Inc: Therma Bright contracts Ridge Global to extend reach2
24.03.Therma Bright Inc.: Therma Bright Partners with Ridge Global to Expand Its United States and Global Reach397Toronto, Ontario--(Newsfile Corp. - March 24, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the AcuVidTM COVID-19 Rapid Antigen Saliva Test and other progressive...
► Artikel lesen
18.03.Therma Bright Inc: Therma Bright to conduct AcuVid study9
18.03.Therma Bright initiates trial for AcuVid COVID-19 rapid saliva-based antigen test4
Seite:  Weiter >>
75 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,18